Key takeaways
Trifluoperazine and ziprasidone (Geodon) are both antipsychotic medications, but they belong to different classes and treat different conditions. Trifluoperazine is a first-generation (typical) antipsychotic mainly used for schizophrenia and anxiety, while ziprasidone is an atypical antipsychotic used for schizophrenia and bipolar I disorder. Trifluoperazine works by making the brain less sensitive to dopamine, whereas ziprasidone balances both dopamine and serotonin levels. Trifluoperazine is usually taken twice daily and is not recommended for long-term use due to the risk of tardive dyskinesia, a condition causing uncontrollable movements. On the other hand, ziprasidone must be taken with food twice daily and can cause heart rhythm problems, which requires careful monitoring. Ziprasidone has a lower risk of weight gain and sleepiness compared to trifluoperazine. Both medications can cause neuroleptic malignant syndrome and increase the risk of death in older adults with dementia-related psychosis.
